INCY (Incyte Corporation) Wutah bathi resik saben saham ing taun iki

INCY (Incyte Pharma) - tandha merek perusahaan

The 12-month earnings per share growth trend highlights the risks of dependence on a single flagship drug, with -53.50 representing the current level of the metric. US laboratories and patent protection ensure business stability. To diversify revenue, Incyte Corporation (INCY) is actively investing in dermatology and mergers to penetrate high-margin market segments.

Wutah bathi saben saham ing taun lumaku: Incyte Corp (INCY) kanggo 04.07.2022 - 15.11.2026

Rincian metrik keuangan lan pasar incyte.com (INCY)

- kuotasi lan prakiraan analis:
Kurs saham Incyte Corp.|INCY - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Biji pasar Incyte Corporation|INCY - Nilai Total Perusahaan
- rincian nilai buku perusahaan:
Nilai Aset Bersih saben Saham Incyte|INCY - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku incyte.com|INCY - Aset Agregat Perusahaan
- rincian utang lan likuiditas:
Utang marang Modal Incyte Corporation|INCY - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas Incyte Corp.|INCY - Gunggung utang perusahaan|Utang-utang marang nilai buku Incyte Corp|INCY - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Incyte|Rasio likuiditas perantara incyte.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
INCY - Bathi resik|Penghasilan resik sing dikarepake Incyte Corporation|INCY - Pangali P/E|Rasio prakiraan rega marang bathi incyte.com|INCY - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Incyte|INCY - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Incyte|INCY - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan incyte.com|INCY - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham ing taun ngarep Incyte Corporation
- data pendapatan lan penerimaan dodolan:
INCY - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan Incyte Pharma|INCY - Rasio rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan Incyte
Ringkesan analisis perusahaan:INCY Incyte Corporation
Produk mawa merek Incyte Corporation

The stability of Incyte Corporation (INCY) is based on the medical community's high level of trust in its innovative oncology drugs. This reputation converts into profit, which the metric measures through the percentage growth of net income per share relative to the previous year. By analyzing the EPS YoY trend, an investor can filter out market noise and determine whether the business is in a phase of fundamental growth or stagnation.

Pesaing wigati

Wutah bathi resik saben saham ing taun iki HUTCHMED Corp|NUVB (nuvationbio.com) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki dayonebio.com (DAWN)|Wutah bathi saben saham ing taun lumaku Monopar Corp (MNPR)|INBX - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku I-Mab Inc. IMAB|Fennec - Wutah bathi saben saham ing taun lumaku|HRTX - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Nuvectis Pharma, Inc.|CHRS: Wutah bathi ing taun lumaku|Owah-owahan bathi resik saben saham ing taun lumaku Corbus Pharma CRBP|Wutah bathi resik saben saham ing taun iki CRDF|Kacepetan wutah bathi saben saham ing taun lumaku BeyondSpring Inc. BYSI|Wutah bathi resik saben saham ing taun iki BCAB (BioAtla Inc)|LIXT (Lixte Biotechnology Holdings, Inc.) - Tambahing bathi saben saham ing taun lumaku|Citius Pharmaceuticals, Inc. - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku CLRB (Cellectar Biosciences, Inc.)|BioLineRx Corp - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku CANF (Can-Fite BioPharma, Ltd.)|APRE: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Kazia (KZIA)|Wutah bathi saben saham ing taun lumaku silexion.com|NCNA: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku CMRX|Wutah bathi ing taun lumaku Cyclacel, Inc. (CYCC)|Wutah bathi saben saham ing taun lumaku G1 Therapeutics Inc. GTHX|KRON (Kronos Bio) - Dinamika bathi saben saham ing taun lumaku|KTRA: Wutah bathi resik saben saham ing taun iki|Kacepetan wutah bathi saben saham ing taun lumaku Oncternal Therapeutics Inc|Portage Biotech (PRTG) - Wutah bathi saben saham ing taun lumaku